Vimarsana
Biggest News Aggregation in the World

Page 4 - Biotechnology Vector News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotechnology Vector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotechnology Vector Today - Breaking & Trending Today

Infoline | Новость: Росіянин з COVID-19 заразив одразу 1,5 тисячі осіб - Vimarsana News

Infoline | Новость: Росіянин з COVID-19 заразив одразу 1,5 тисячі осіб

У Росії один пацієнт із коронавірусом заразив інфекцією одразу 1,5 тисячі осіб. Це максимальний випадок суперпоширення, який зафіксували в країні, пише ТАСС з посиланням на главу філії Державного наук

Russia's EpiVacCorona vaccine expected to provide immunity for one year — developer - Society & Culture - Vimarsana News

Russia's EpiVacCorona vaccine expected to provide immunity for one year — developer - Society & Culture

The estimates were based on research involving the first group of volunteers who had received the vaccine nine months back

Source: tass.com
Venezuela launches clinical trials of Russia's EpiVacCorona jab - World - Vimarsana News

Venezuela launches clinical trials of Russia's EpiVacCorona jab - World

Venezuela launches clinical trials of Russia’s EpiVacCorona jab Acting Vice President of Venezuela Delcy Rodriguez expressed confidence that this is "a good vaccine" and hoped that Venezuela would be able to use it to inoculate its population Russian Ambassador to Venezuela Sergei Melik-Bagdasarov© Andrei Ulinkin/TASS RIO DE JANEIRO, May 5. /TASS/. Venezuela has launched clinical trials of Russia’s EpiVacCorona vaccine on Tuesday. Russian Ambassador to Venezuela Sergei Melik-Bagdasarov was the first volunteer to take part in the trials, the diplomat informed TASS. The vaccination ev...

Source: tass.com
Over 90% inoculated with EpiVacCorona jab developed COVID-19 antibodies, says researcher - Vimarsana News

Over 90% inoculated with EpiVacCorona jab developed COVID-19 antibodies, says researcher

Over 90% inoculated with EpiVacCorona jab developed COVID-19 antibodies, says researcher EpiVacCorona, developed by the Russian sanitary watchdog’s State Research Center of Virology and Biotechnology Vector, is Russia’s second coronavirus vaccine © Maxim Slutsky/TASS MOSCOW, May 5. /TASS/. More than 90% of people inoculated with the EpiVacCorona vaccine developed antibodies to COVID-19, Chief of the Russian State Research Center of Virology and Biotechnology Vector’s zoonotic infections and influenza department Alexander Ryzhikov said in a video posted on the Instagram page of ...

Source: tass.com
Center Vector to check if EpiVacCorona is effective against Indian virus strain - Vimarsana News

Center Vector to check if EpiVacCorona is effective against Indian virus strain

Center Vector to check if EpiVacCorona is effective against Indian virus strain Earlier, the head of Russia’s consumer rights watchdog Anna Popova said that Russia had requested a sample of the Indian strain of the coronavirus and it would be obtained for examination soon MOSCOW, May 3. /TASS/. Russia’s research center Vector is going to test the effectiveness of its vaccine EpiVacCorona, against the Indian strain of the coronavirus as soon as it becomes available, the center’s deputy chief, Tatyana Nepomnyashchikh, said in the evening news program Vesti on the Rossiya-1 federal tele...

Source: tass.com